English

cbdMD, Inc.

EDGAR

YCBD Quarterly report (10-Q) · filed 2026-08-13

Annual consolidated revenue for 2025: about USD 19.19M, using the latest reported figures. The previous period, 2024, was about USD 19.48M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

5.55 million USD

2026 Q3 · USD

Exact inputs and evidence

Revenue: 5553738 USD Source

Operating margin

-20.36%

2026 Q3 · %

Exact inputs and evidence

Operating Income: -1130477 USD Source
Revenue: 5553738 USD Source

Operating cash flow

-442 thousand USD

2026 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -1977122 USD Source
Operating Cash Flow: -1534964 USD Source

Free cash flow

-460 thousand USD

2026 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -1977122 USD Source
Operating Cash Flow: -1534964 USD Source
Capital Expenditure: 188615 USD Source
Capital Expenditure: 170550 USD Source

Cash and cash equivalents: 2.12 million USD 2026-06-30 Source
Exact value

2118339 USD
Long-term debt including current maturities: Not available
Shares outstanding: 11.1 million shares 2026-06-30 Source
Exact value

11118820 shares

Reported share-count change

24.81% · 2.21 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

8908444 shares · 2025-06-30· Source
11118820 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

20.9 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Revenue: 19190468 USD · 2024-10-01 – 2025-09-30 Source
Revenue: 14469698 USD · 2024-10-01 – 2025-06-30 Source
Revenue: 5016904 USD · 2025-10-01 – 2025-12-31 Source
Revenue: 5640059 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 5553738 USD · 2026-04-01 – 2026-06-30 Source

Net income

-2.89 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -2040902 USD · 2024-10-01 – 2025-09-30 Source
Net income: -1360934 USD · 2024-10-01 – 2025-06-30 Source
Net income: -283131 USD · 2025-10-01 – 2025-12-31 Source
Net income: -797978 USD · 2026-01-01 – 2026-03-31 Source
Net income: -1127202 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-2.22 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -1452375 USD · 2024-10-01 – 2025-09-30 Source
Operating cash flow: -1211626 USD · 2024-10-01 – 2025-06-30 Source
Operating cash flow: -812464 USD · 2025-10-01 – 2025-12-31 Source
Operating cash flow: -1534964 USD · 2025-10-01 – 2026-03-31 Source
Operating cash flow: -812464 USD · 2025-10-01 – 2025-12-31 Source
Operating cash flow: -1977122 USD · 2025-10-01 – 2026-06-30 Source
Operating cash flow: -1534964 USD · 2025-10-01 – 2026-03-31 Source

Capital expenditure

191 thousand USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Capital expenditure: 184172 USD · 2024-10-01 – 2025-09-30 Source
Capital expenditure: 181368 USD · 2024-10-01 – 2025-06-30 Source
Capital expenditure: 164802 USD · 2025-10-01 – 2025-12-31 Source
Capital expenditure: 170550 USD · 2025-10-01 – 2026-03-31 Source
Capital expenditure: 164802 USD · 2025-10-01 – 2025-12-31 Source
Capital expenditure: 188615 USD · 2025-10-01 – 2026-06-30 Source
Capital expenditure: 170550 USD · 2025-10-01 – 2026-03-31 Source

Free cash flow

-2.41 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -1452375 USD · 2024-10-01 – 2025-09-30 Source
Operating cash flow: -1211626 USD · 2024-10-01 – 2025-06-30 Source
Operating cash flow: -812464 USD · 2025-10-01 – 2025-12-31 Source
Operating cash flow: -1534964 USD · 2025-10-01 – 2026-03-31 Source
Operating cash flow: -812464 USD · 2025-10-01 – 2025-12-31 Source
Operating cash flow: -1977122 USD · 2025-10-01 – 2026-06-30 Source
Operating cash flow: -1534964 USD · 2025-10-01 – 2026-03-31 Source
Capital expenditure: 184172 USD · 2024-10-01 – 2025-09-30 Source
Capital expenditure: 181368 USD · 2024-10-01 – 2025-06-30 Source
Capital expenditure: 164802 USD · 2025-10-01 – 2025-12-31 Source
Capital expenditure: 170550 USD · 2025-10-01 – 2026-03-31 Source
Capital expenditure: 164802 USD · 2025-10-01 – 2025-12-31 Source
Capital expenditure: 188615 USD · 2025-10-01 – 2026-06-30 Source
Capital expenditure: 170550 USD · 2025-10-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-13.

Financial data available through: 2025-09-30.

Coverage by financial measure

Revenue: 10 of 11 periods available· newest 2025-09-30
Operating income: 10 of 11 periods available· newest 2025-09-30
Net income: 10 of 11 periods available· newest 2025-09-30
Operating cash flow: 10 of 11 periods available· newest 2025-09-30
Capital expenditure: 5 of 11 periods available· newest 2025-09-30
Total assets: 10 of 11 periods available· newest 2025-09-30
Total liabilities: 10 of 11 periods available· newest 2025-09-30
Current assets: 10 of 11 periods available· newest 2025-09-30
Current liabilities: 10 of 11 periods available· newest 2025-09-30
Cash and cash equivalents: 10 of 11 periods available· newest 2025-09-30
long term debt: No compatible figures in this window
Shares outstanding: 10 of 11 periods available· newest 2025-09-30

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-1.5%

Prior period

USD 19.48 million

2023-10-01 – 2024-09-30
Current period

USD 19.19 million

2024-10-01 – 2025-09-30

Exact inputs and evidence

19190468 − 19482167 = -291699 USD

19482167 USD · 2023-10-01 – 2024-09-30
Inspect prior input Prior source
19190468 USD · 2024-10-01 – 2025-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · cbdMD, Inc. · 2025-09-30 cbdMD, Inc. (edgar:1644903) Year-over-year change in Revenue: -291699 USD Concept: fundies:Revenue Period: 2024-10-01 to 2025-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 19190468 USD (2024-10-01 to 2025-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774925038435/ycbd20250930_10k.htm#1151351 Filing: 000143774925038435 Input fundies:Revenue: 19482167 USD (2023-10-01 to 2024-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774925038435/ycbd20250930_10k.htm#1152783 Filing: 000143774925038435
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 1.66 million

Prior period

−USD 3.7 million

2023-10-01 – 2024-09-30
Current period

−USD 2.04 million

2024-10-01 – 2025-09-30

Exact inputs and evidence

-2040902 − -3700126 = 1659224 USD

-3700126 USD · 2023-10-01 – 2024-09-30
Inspect prior input Prior source
-2040902 USD · 2024-10-01 – 2025-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · cbdMD, Inc. · 2025-09-30 cbdMD, Inc. (edgar:1644903) Year-over-year change in Net income: 1659224 USD Concept: fundies:NetIncome Period: 2024-10-01 to 2025-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -2040902 USD (2024-10-01 to 2025-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774925038435/ycbd20250930_10k.htm#1420058 Filing: 000143774925038435 Input fundies:NetIncome: -3700126 USD (2023-10-01 to 2024-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774925038435/ycbd20250930_10k.htm#1420866 Filing: 000143774925038435
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 1.1 million

Prior period

−USD 352,792

2023-10-01 – 2024-09-30
Current period

−USD 1.45 million

2024-10-01 – 2025-09-30

Exact inputs and evidence

-1452375 − -352792 = -1099583 USD

-352792 USD · 2023-10-01 – 2024-09-30
Inspect prior input Prior source
-1452375 USD · 2024-10-01 – 2025-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · cbdMD, Inc. · 2025-09-30 cbdMD, Inc. (edgar:1644903) Year-over-year change in Operating cash flow: -1099583 USD Concept: fundies:OperatingCashFlow Period: 2024-10-01 to 2025-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1452375 USD (2024-10-01 to 2025-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774925038435/ycbd20250930_10k.htm#887308 Filing: 000143774925038435 Input fundies:OperatingCashFlow: -352792 USD (2023-10-01 to 2024-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774925038435/ycbd20250930_10k.htm#887953 Filing: 000143774925038435
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-3.1%

Prior period

USD 190,015

2023-10-01 – 2024-09-30
Current period

USD 184,172

2024-10-01 – 2025-09-30

Exact inputs and evidence

184172 − 190015 = -5843 USD

190015 USD · 2023-10-01 – 2024-09-30
Inspect prior input Prior source
184172 USD · 2024-10-01 – 2025-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · cbdMD, Inc. · 2025-09-30 cbdMD, Inc. (edgar:1644903) Year-over-year change in Capital expenditure: -5843 USD Concept: fundies:CapitalExpenditure Period: 2024-10-01 to 2025-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 184172 USD (2024-10-01 to 2025-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774925038435/ycbd20250930_10k.htm#891383 Filing: 000143774925038435 Input fundies:CapitalExpenditure: 190015 USD (2023-10-01 to 2024-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774925038435/ycbd20250930_10k.htm#892092 Filing: 000143774925038435
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2024-10-01 – 2025-09-30

Revenue USD 19.19 million 100% of revenue
Operating costs Derived USD 21.35 million 111% of revenue
Operating income −USD 2.16 million −11% of revenue
Tax, interest and other Derived −USD 121,688 −0.6% of revenue
Net income −USD 2.04 million −11% of revenue

Cash

Operating cash flow −USD 1.45 million −7.6% of revenue
Capital expenditure USD 184,172 1% of revenue
Free cash flow Derived −USD 1.64 million −8.5% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Operating loss: operating costs were 291% of revenue.
2017 Operating loss: operating costs were 130% of revenue.
2018 Operating loss: operating costs were 491% of revenue.
2019 Operating loss: operating costs were 163% of revenue.
2020 Operating loss: operating costs were 142% of revenue.
2021 Operating loss: operating costs were 144% of revenue.
2022 Operating loss: operating costs were 321% of revenue.
2023 Operating loss: operating costs were 193% of revenue.
2024 Operating loss: operating costs were 117% of revenue.
2025 Operating loss: operating costs were 111% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2015-10-01 – 2016-09-30	2031562	5919832 Derived	-3888270	8000 Derived	-3896270	Unavailable	Source 2015-10-01 – 2016-09-30: 2031562 USD Inspect Revenue Open source 2015-10-01 – 2016-09-30: -3888270 USD Inspect Operating Income Open source 2015-10-01 – 2016-09-30: -3896270 USD Inspect Net Income Open source 2015-10-01 – 2016-09-30: -2897254 USD Inspect Operating Cash Flow Open source
2017 2016-10-01 – 2017-09-30	4474953	5836121 Derived	-1361168	25000 Derived	-1386168	Unavailable	Source 2016-10-01 – 2017-09-30: 4474953 USD Inspect Revenue Open source 2016-10-01 – 2017-09-30: -1361168 USD Inspect Operating Income Open source 2016-10-01 – 2017-09-30: -1386168 USD Inspect Net Income Open source 2016-10-01 – 2017-09-30: -2329841 USD Inspect Operating Cash Flow Open source
2018 2017-10-01 – 2018-09-30	459091	2256159 Derived	-1797068	-1859902 Derived	62834	Unavailable	Source 2017-10-01 – 2018-09-30: 459091 USD Inspect Revenue Open source 2017-10-01 – 2018-09-30: -1797068 USD Inspect Operating Income Open source 2017-10-01 – 2018-09-30: 62834 USD Inspect Net Income Open source 2017-10-01 – 2018-09-30: -5573095 USD Inspect Operating Cash Flow Open source
2019 2018-10-01 – 2019-09-30	23651551	38448442 Derived	-14796891	36560658 Derived	-51357549	Unavailable	Source 2018-10-01 – 2019-09-30: 23651551 USD Inspect Revenue Open source 2018-10-01 – 2019-09-30: -14796891 USD Inspect Operating Income Open source 2018-10-01 – 2019-09-30: -51357549 USD Inspect Net Income Open source 2018-10-01 – 2019-09-30: -15377467 USD Inspect Operating Cash Flow Open source
2020 2019-10-01 – 2020-09-30	41883734	59465589 Derived	-17581855	-30184128 Derived	12602273	Unavailable	Source 2019-10-01 – 2020-09-30: 41883734 USD Inspect Revenue Open source 2019-10-01 – 2020-09-30: -17581855 USD Inspect Operating Income Open source 2019-10-01 – 2020-09-30: 12602273 USD Inspect Net Income Open source 2019-10-01 – 2020-09-30: -10664335 USD Inspect Operating Cash Flow Open source
2021 2020-10-01 – 2021-09-30	44480763	64096753 Derived	-19615990	3778899 Derived	-23394889	-14435446 Derived	Source 2020-10-01 – 2021-09-30: 44480763 USD Inspect Revenue Open source 2020-10-01 – 2021-09-30: -19615990 USD Inspect Operating Income Open source 2020-10-01 – 2021-09-30: -23394889 USD Inspect Net Income Open source 2020-10-01 – 2021-09-30: -14093433 USD Inspect Operating Cash Flow Open source 2020-10-01 – 2021-09-30: 342013 USD Inspect Capital Expenditure Open source
2022 2021-10-01 – 2022-09-30	35403224	113669739 Derived	-78266515	-8182822 Derived	-70083693	-15655830 Derived	Source 2021-10-01 – 2022-09-30: 35403224 USD Inspect Revenue Open source 2021-10-01 – 2022-09-30: -78266515 USD Inspect Operating Income Open source 2021-10-01 – 2022-09-30: -70083693 USD Inspect Net Income Open source 2021-10-01 – 2022-09-30: -14967150 USD Inspect Operating Cash Flow Open source 2021-10-01 – 2022-09-30: 688680 USD Inspect Capital Expenditure Open source
2023 2022-10-01 – 2023-09-30	24155362	46642911 Derived	-22487549	450660 Derived	-22938209	-4599600 Derived	Source 2022-10-01 – 2023-09-30: 24155362 USD Inspect Revenue Open source 2022-10-01 – 2023-09-30: -22487549 USD Inspect Operating Income Open source 2022-10-01 – 2023-09-30: -22938209 USD Inspect Net Income Open source 2022-10-01 – 2023-09-30: -4302051 USD Inspect Operating Cash Flow Open source 2022-10-01 – 2023-09-30: 297549 USD Inspect Capital Expenditure Open source
2024 2023-10-01 – 2024-09-30	19482167	22797577 Derived	-3315410	384716 Derived	-3700126	-542807 Derived	Source 2023-10-01 – 2024-09-30: 19482167 USD Inspect Revenue Open source 2023-10-01 – 2024-09-30: -3315410 USD Inspect Operating Income Open source 2023-10-01 – 2024-09-30: -3700126 USD Inspect Net Income Open source 2023-10-01 – 2024-09-30: -352792 USD Inspect Operating Cash Flow Open source 2023-10-01 – 2024-09-30: 190015 USD Inspect Capital Expenditure Open source
2025 2024-10-01 – 2025-09-30	19190468	21353058 Derived	-2162590	-121688 Derived	-2040902	-1636547 Derived	Source 2024-10-01 – 2025-09-30: 19190468 USD Inspect Revenue Open source 2024-10-01 – 2025-09-30: -2162590 USD Inspect Operating Income Open source 2024-10-01 – 2025-09-30: -2040902 USD Inspect Net Income Open source 2024-10-01 – 2025-09-30: -1452375 USD Inspect Operating Cash Flow Open source 2024-10-01 – 2025-09-30: 184172 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 19.2M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-09-30	Revenue	2031562	Revenue: 2031562 Open source
20172017-09-30	Revenue	4474953	Revenue: 4474953 Open source
20182018-09-30	Revenue	459091	Revenue: 459091 Open source
20192019-09-30	Revenue	23651551	Revenue: 23651551 Open source
20202020-09-30	Revenue	41883734	Revenue: 41883734 Open source
20212021-09-30	Revenue	44480763	Revenue: 44480763 Open source
20222022-09-30	Revenue	35403224	Revenue: 35403224 Open source
20232023-09-30	Revenue	24155362	Revenue: 24155362 Open source
20242024-09-30	Revenue	19482167	Revenue: 19482167 Open source
20252025-09-30	Revenue	19190468	Revenue: 19190468 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-1.5% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-09-30	Year over year	No prior comparable period	Revenue: 2031562 Open source
20172017-09-30	Year over year	120.3%	Revenue: 4474953 Open source Revenue: 2031562 Open source
20182018-09-30	Year over year	-89.7%	Revenue: 459091 Open source Revenue: 4474953 Open source
20192019-09-30	Year over year	5,051.8%	Revenue: 23651551 Open source Revenue: 459091 Open source
20202020-09-30	Year over year	77.1%	Revenue: 41883734 Open source Revenue: 23651551 Open source
20212021-09-30	Year over year	6.2%	Revenue: 44480763 Open source Revenue: 41883734 Open source
20222022-09-30	Year over year	-20.4%	Revenue: 35403224 Open source Revenue: 44480763 Open source
20232023-09-30	Year over year	-31.8%	Revenue: 24155362 Open source Revenue: 35403224 Open source
20242024-09-30	Year over year	-19.3%	Revenue: 19482167 Open source Revenue: 24155362 Open source
20252025-09-30	Year over year	-1.5%	Revenue: 19190468 Open source Revenue: 19482167 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -11.3% 2025

Net margin -10.6% 2025

Free cash flow margin -8.5% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-09-30	Operating margin	-191.4%	Operating Income: -3888270 Open source Revenue: 2031562 Open source
20172017-09-30	Operating margin	-30.4%	Operating Income: -1361168 Open source Revenue: 4474953 Open source
20182018-09-30	Operating margin	-391.4%	Operating Income: -1797068 Open source Revenue: 459091 Open source
20192019-09-30	Operating margin	-62.6%	Operating Income: -14796891 Open source Revenue: 23651551 Open source
20202020-09-30	Operating margin	-42%	Operating Income: -17581855 Open source Revenue: 41883734 Open source
20212021-09-30	Operating margin	-44.1%	Operating Income: -19615990 Open source Revenue: 44480763 Open source
20222022-09-30	Operating margin	-221.1%	Operating Income: -78266515 Open source Revenue: 35403224 Open source
20232023-09-30	Operating margin	-93.1%	Operating Income: -22487549 Open source Revenue: 24155362 Open source
20242024-09-30	Operating margin	-17%	Operating Income: -3315410 Open source Revenue: 19482167 Open source
20252025-09-30	Operating margin	-11.3%	Operating Income: -2162590 Open source Revenue: 19190468 Open source
20162016-09-30	Net margin	-191.8%	Net Income: -3896270 Open source Revenue: 2031562 Open source
20172017-09-30	Net margin	-31%	Net Income: -1386168 Open source Revenue: 4474953 Open source
20182018-09-30	Net margin	13.7%	Net Income: 62834 Open source Revenue: 459091 Open source
20192019-09-30	Net margin	-217.1%	Net Income: -51357549 Open source Revenue: 23651551 Open source
20202020-09-30	Net margin	30.1%	Net Income: 12602273 Open source Revenue: 41883734 Open source
20212021-09-30	Net margin	-52.6%	Net Income: -23394889 Open source Revenue: 44480763 Open source
20222022-09-30	Net margin	-198%	Net Income: -70083693 Open source Revenue: 35403224 Open source
20232023-09-30	Net margin	-95%	Net Income: -22938209 Open source Revenue: 24155362 Open source
20242024-09-30	Net margin	-19%	Net Income: -3700126 Open source Revenue: 19482167 Open source
20252025-09-30	Net margin	-10.6%	Net Income: -2040902 Open source Revenue: 19190468 Open source
20162016-09-30	Free cash flow margin	Not reported	Revenue: 2031562 Open source Operating Cash Flow: -2897254 Open source
20172017-09-30	Free cash flow margin	Not reported	Revenue: 4474953 Open source Operating Cash Flow: -2329841 Open source
20182018-09-30	Free cash flow margin	Not reported	Revenue: 459091 Open source Operating Cash Flow: -5573095 Open source
20192019-09-30	Free cash flow margin	Not reported	Revenue: 23651551 Open source Operating Cash Flow: -15377467 Open source
20202020-09-30	Free cash flow margin	Not reported	Revenue: 41883734 Open source Operating Cash Flow: -10664335 Open source
20212021-09-30	Free cash flow margin	-32.5%	Revenue: 44480763 Open source Operating Cash Flow: -14093433 Open source Capital Expenditure: 342013 Open source
20222022-09-30	Free cash flow margin	-44.2%	Revenue: 35403224 Open source Operating Cash Flow: -14967150 Open source Capital Expenditure: 688680 Open source
20232023-09-30	Free cash flow margin	-19%	Revenue: 24155362 Open source Operating Cash Flow: -4302051 Open source Capital Expenditure: 297549 Open source
20242024-09-30	Free cash flow margin	-2.8%	Revenue: 19482167 Open source Operating Cash Flow: -352792 Open source Capital Expenditure: 190015 Open source
20252025-09-30	Free cash flow margin	-8.5%	Revenue: 19190468 Open source Operating Cash Flow: -1452375 Open source Capital Expenditure: 184172 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1.5M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-09-30	Operating cash flow	-2897254	Operating Cash Flow: -2897254 Open source
20172017-09-30	Operating cash flow	-2329841	Operating Cash Flow: -2329841 Open source
20182018-09-30	Operating cash flow	-5573095	Operating Cash Flow: -5573095 Open source
20192019-09-30	Operating cash flow	-15377467	Operating Cash Flow: -15377467 Open source
20202020-09-30	Operating cash flow	-10664335	Operating Cash Flow: -10664335 Open source
20212021-09-30	Operating cash flow	-14093433	Operating Cash Flow: -14093433 Open source
20222022-09-30	Operating cash flow	-14967150	Operating Cash Flow: -14967150 Open source
20232023-09-30	Operating cash flow	-4302051	Operating Cash Flow: -4302051 Open source
20242024-09-30	Operating cash flow	-352792	Operating Cash Flow: -352792 Open source
20252025-09-30	Operating cash flow	-1452375	Operating Cash Flow: -1452375 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -1.6M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-09-30	Free cash flow	Unavailable	Operating Cash Flow: -2897254 Open source
20172017-09-30	Free cash flow	Unavailable	Operating Cash Flow: -2329841 Open source
20182018-09-30	Free cash flow	Unavailable	Operating Cash Flow: -5573095 Open source
20192019-09-30	Free cash flow	Unavailable	Operating Cash Flow: -15377467 Open source
20202020-09-30	Free cash flow	Unavailable	Operating Cash Flow: -10664335 Open source
20212021-09-30	Free cash flow	-14435446	Operating Cash Flow: -14093433 Open source Capital Expenditure: 342013 Open source
20222022-09-30	Free cash flow	-15655830	Operating Cash Flow: -14967150 Open source Capital Expenditure: 688680 Open source
20232023-09-30	Free cash flow	-4599600	Operating Cash Flow: -4302051 Open source Capital Expenditure: 297549 Open source
20242024-09-30	Free cash flow	-542807	Operating Cash Flow: -352792 Open source Capital Expenditure: 190015 Open source
20252025-09-30	Free cash flow	-1636547	Operating Cash Flow: -1452375 Open source Capital Expenditure: 184172 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

30.7% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20162016-09-30	Liabilities / assets	118%	Total Liabilities: 1916083 Open source Total Assets: 1623358 Open source
20172017-09-30	Liabilities / assets	27.2%	Total Liabilities: 1920525 Open source Total Assets: 7069439 Open source
20182018-09-30	Liabilities / assets	6.6%	Total Liabilities: 998457 Open source Total Assets: 15017612 Open source
20192019-09-30	Liabilities / assets	60.2%	Total Liabilities: 56914138 Open source Total Assets: 94518122 Open source
20202020-09-30	Liabilities / assets	28.6%	Total Liabilities: 31660753 Open source Total Assets: 110842801 Open source
20212021-09-30	Liabilities / assets	17.4%	Total Liabilities: 21741189 Open source Total Assets: 124883376 Open source
20222022-09-30	Liabilities / assets	23%	Total Liabilities: 9367478 Open source Total Assets: 40791909 Open source
20232023-09-30	Liabilities / assets	44.2%	Total Liabilities: 7163999 Open source Total Assets: 16195283 Open source
20242024-09-30	Liabilities / assets	81.4%	Total Liabilities: 8618040 Open source Total Assets: 10581457 Open source
20252025-09-30	Liabilities / assets	30.7%	Total Liabilities: 3193843 Open source Total Assets: 10419950 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.05× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20162016-09-30	Current assets / current liabilities	0.5×	Current Assets: 956317 Open source Current Liabilities: 1904083 Open source
20172017-09-30	Current assets / current liabilities	2.42×	Current Assets: 3693676 Open source Current Liabilities: 1523525 Open source
20182018-09-30	Current assets / current liabilities	12.16×	Current Assets: 11790147 Open source Current Liabilities: 969955 Open source
20192019-09-30	Current assets / current liabilities	4.24×	Current Assets: 15743035 Open source Current Liabilities: 3709878 Open source
20202020-09-30	Current assets / current liabilities	3.08×	Current Assets: 23712252 Open source Current Liabilities: 7689078 Open source
20212021-09-30	Current assets / current liabilities	5.28×	Current Assets: 36502360 Open source Current Liabilities: 6917146 Open source
20222022-09-30	Current assets / current liabilities	3.03×	Current Assets: 16011603 Open source Current Liabilities: 5285612 Open source
20232023-09-30	Current assets / current liabilities	1.73×	Current Assets: 8070041 Open source Current Liabilities: 4670341 Open source
20242024-09-30	Current assets / current liabilities	0.74×	Current Assets: 6389084 Open source Current Liabilities: 8618040 Open source
20252025-09-30	Current assets / current liabilities	2.05×	Current Assets: 6551429 Open source Current Liabilities: 3193843 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2015-10-01 – 2016-09-30	−USD 3.9 million Exact value Exact value: -3896270 USD 2015-10-01 – 2016-09-30: -3896270 USD Inspect Net Income Open source Share or cite Citation for Net Income · cbdMD, Inc. · 2016-09-30 cbdMD, Inc. (edgar:1644903) Net Income: -3896270 USD Concept: fundies:NetIncome Period: 2015-10-01 to 2016-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903/explain?concept=fundies%3ANetIncome&period=2016-09-30&surface=latest&period_type=duration&start=2015-10-01&unit=USD&dimensions= Input fundies:NetIncome: -3896270 USD (2015-10-01 to 2016-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000165495417011858/levb-20170930.xml#73760 Filing: 000165495417011858 The citation records this snapshot. The page link may show a newer release later.	−USD 2.9 million Exact value Exact value: -2897254 USD 2015-10-01 – 2016-09-30: -2897254 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · cbdMD, Inc. · 2016-09-30 cbdMD, Inc. (edgar:1644903) Operating Cash Flow: -2897254 USD Concept: fundies:OperatingCashFlow Period: 2015-10-01 to 2016-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903/explain?concept=fundies%3AOperatingCashFlow&period=2016-09-30&surface=latest&period_type=duration&start=2015-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2897254 USD (2015-10-01 to 2016-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000165495417011858/levb-20170930.xml#78426 Filing: 000165495417011858 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2017 2016-10-01 – 2017-09-30	−USD 1.39 million Exact value Exact value: -1386168 USD 2016-10-01 – 2017-09-30: -1386168 USD Inspect Net Income Open source Share or cite Citation for Net Income · cbdMD, Inc. · 2017-09-30 cbdMD, Inc. (edgar:1644903) Net Income: -1386168 USD Concept: fundies:NetIncome Period: 2016-10-01 to 2017-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903/explain?concept=fundies%3ANetIncome&period=2017-09-30&surface=latest&period_type=duration&start=2016-10-01&unit=USD&dimensions= Input fundies:NetIncome: -1386168 USD (2016-10-01 to 2017-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000165495418013865/levb-20180930.xml#82779 Filing: 000165495418013865 The citation records this snapshot. The page link may show a newer release later.	−USD 2.33 million Exact value Exact value: -2329841 USD 2016-10-01 – 2017-09-30: -2329841 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · cbdMD, Inc. · 2017-09-30 cbdMD, Inc. (edgar:1644903) Operating Cash Flow: -2329841 USD Concept: fundies:OperatingCashFlow Period: 2016-10-01 to 2017-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903/explain?concept=fundies%3AOperatingCashFlow&period=2017-09-30&surface=latest&period_type=duration&start=2016-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2329841 USD (2016-10-01 to 2017-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000165495418013865/levb-20180930.xml#161121 Filing: 000165495418013865 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2018 2017-10-01 – 2018-09-30	USD 62,834 Exact value Exact value: 62834 USD 2017-10-01 – 2018-09-30: 62834 USD Inspect Net Income Open source Share or cite Citation for Net Income · cbdMD, Inc. · 2018-09-30 cbdMD, Inc. (edgar:1644903) Net Income: 62834 USD Concept: fundies:NetIncome Period: 2017-10-01 to 2018-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903/explain?concept=fundies%3ANetIncome&period=2018-09-30&surface=latest&period_type=duration&start=2017-10-01&unit=USD&dimensions= Input fundies:NetIncome: 62834 USD (2017-10-01 to 2018-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000165495419014052/ycbd-20190930.xml#161167 Filing: 000165495419014052 The citation records this snapshot. The page link may show a newer release later.	−USD 5.57 million Exact value Exact value: -5573095 USD 2017-10-01 – 2018-09-30: -5573095 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · cbdMD, Inc. · 2018-09-30 cbdMD, Inc. (edgar:1644903) Operating Cash Flow: -5573095 USD Concept: fundies:OperatingCashFlow Period: 2017-10-01 to 2018-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903/explain?concept=fundies%3AOperatingCashFlow&period=2018-09-30&surface=latest&period_type=duration&start=2017-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5573095 USD (2017-10-01 to 2018-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000165495419014052/ycbd-20190930.xml#170383 Filing: 000165495419014052 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2019 2018-10-01 – 2019-09-30	−USD 51.36 million Exact value Exact value: -51357549 USD 2018-10-01 – 2019-09-30: -51357549 USD Inspect Net Income Open source Share or cite Citation for Net Income · cbdMD, Inc. · 2019-09-30 cbdMD, Inc. (edgar:1644903) Net Income: -51357549 USD Concept: fundies:NetIncome Period: 2018-10-01 to 2019-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903/explain?concept=fundies%3ANetIncome&period=2019-09-30&surface=latest&period_type=duration&start=2018-10-01&unit=USD&dimensions= Input fundies:NetIncome: -51357549 USD (2018-10-01 to 2019-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000165495420013835/ycbd-20200930.xml#169460 Filing: 000165495420013835 The citation records this snapshot. The page link may show a newer release later.	−USD 15.38 million Exact value Exact value: -15377467 USD 2018-10-01 – 2019-09-30: -15377467 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · cbdMD, Inc. · 2019-09-30 cbdMD, Inc. (edgar:1644903) Operating Cash Flow: -15377467 USD Concept: fundies:OperatingCashFlow Period: 2018-10-01 to 2019-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903/explain?concept=fundies%3AOperatingCashFlow&period=2019-09-30&surface=latest&period_type=duration&start=2018-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15377467 USD (2018-10-01 to 2019-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000165495420013835/ycbd-20200930.xml#181778 Filing: 000165495420013835 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2020 2019-10-01 – 2020-09-30	USD 12.6 million Exact value Exact value: 12602273 USD 2019-10-01 – 2020-09-30: 12602273 USD Inspect Net Income Open source Share or cite Citation for Net Income · cbdMD, Inc. · 2020-09-30 cbdMD, Inc. (edgar:1644903) Net Income: 12602273 USD Concept: fundies:NetIncome Period: 2019-10-01 to 2020-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903/explain?concept=fundies%3ANetIncome&period=2020-09-30&surface=latest&period_type=duration&start=2019-10-01&unit=USD&dimensions= Input fundies:NetIncome: 12602273 USD (2019-10-01 to 2020-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000165495421013292/ycbd_10k.htm#1494458 Filing: 000165495421013292 The citation records this snapshot. The page link may show a newer release later.	−USD 10.66 million Exact value Exact value: -10664335 USD 2019-10-01 – 2020-09-30: -10664335 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · cbdMD, Inc. · 2020-09-30 cbdMD, Inc. (edgar:1644903) Operating Cash Flow: -10664335 USD Concept: fundies:OperatingCashFlow Period: 2019-10-01 to 2020-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903/explain?concept=fundies%3AOperatingCashFlow&period=2020-09-30&surface=latest&period_type=duration&start=2019-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10664335 USD (2019-10-01 to 2020-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000165495421013292/ycbd_10k.htm#788472 Filing: 000165495421013292 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2020-10-01 – 2021-09-30	−USD 23.39 million Exact value Exact value: -23394889 USD 2020-10-01 – 2021-09-30: -23394889 USD Inspect Net Income Open source Share or cite Citation for Net Income · cbdMD, Inc. · 2021-09-30 cbdMD, Inc. (edgar:1644903) Net Income: -23394889 USD Concept: fundies:NetIncome Period: 2020-10-01 to 2021-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903/explain?concept=fundies%3ANetIncome&period=2021-09-30&surface=latest&period_type=duration&start=2020-10-01&unit=USD&dimensions= Input fundies:NetIncome: -23394889 USD (2020-10-01 to 2021-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774922029136/ycbd20220930_10k.htm#1716060 Filing: 000143774922029136 The citation records this snapshot. The page link may show a newer release later.	−USD 14.09 million Exact value Exact value: -14093433 USD 2020-10-01 – 2021-09-30: -14093433 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · cbdMD, Inc. · 2021-09-30 cbdMD, Inc. (edgar:1644903) Operating Cash Flow: -14093433 USD Concept: fundies:OperatingCashFlow Period: 2020-10-01 to 2021-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903/explain?concept=fundies%3AOperatingCashFlow&period=2021-09-30&surface=latest&period_type=duration&start=2020-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14093433 USD (2020-10-01 to 2021-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774922029136/ycbd20220930_10k.htm#917991 Filing: 000143774922029136 The citation records this snapshot. The page link may show a newer release later.	USD 342,013 Exact value Exact value: 342013 USD 2020-10-01 – 2021-09-30: 342013 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · cbdMD, Inc. · 2021-09-30 cbdMD, Inc. (edgar:1644903) Capital Expenditure: 342013 USD Concept: fundies:CapitalExpenditure Period: 2020-10-01 to 2021-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903/explain?concept=fundies%3ACapitalExpenditure&period=2021-09-30&surface=latest&period_type=duration&start=2020-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 342013 USD (2020-10-01 to 2021-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774922029136/ycbd20220930_10k.htm#925320 Filing: 000143774922029136 The citation records this snapshot. The page link may show a newer release later.	−USD 14.44 million Calculation and evidence -14093433 − 342013 USD Exact free cash flow: -14435446 USD 2020-10-01 – 2021-09-30: -14093433 USD · Inspect Operating Cash Flow · Source 2020-10-01 – 2021-09-30: 342013 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · cbdMD, Inc. · 2021-09-30 cbdMD, Inc. (edgar:1644903) Free cash flow: -14435446 USD Concept: free-cash-flow Period: 2020-10-01 to 2021-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14093433 USD (2020-10-01 to 2021-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774922029136/ycbd20220930_10k.htm#917991 Filing: 000143774922029136 Input fundies:CapitalExpenditure: 342013 USD (2020-10-01 to 2021-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774922029136/ycbd20220930_10k.htm#925320 Filing: 000143774922029136 The citation records this snapshot. The page link may show a newer release later.
2022 2021-10-01 – 2022-09-30	−USD 70.08 million Exact value Exact value: -70083693 USD 2021-10-01 – 2022-09-30: -70083693 USD Inspect Net Income Open source Share or cite Citation for Net Income · cbdMD, Inc. · 2022-09-30 cbdMD, Inc. (edgar:1644903) Net Income: -70083693 USD Concept: fundies:NetIncome Period: 2021-10-01 to 2022-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903/explain?concept=fundies%3ANetIncome&period=2022-09-30&surface=latest&period_type=duration&start=2021-10-01&unit=USD&dimensions= Input fundies:NetIncome: -70083693 USD (2021-10-01 to 2022-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774923035228/ycbd20230930_10k.htm#1680761 Filing: 000143774923035228 The citation records this snapshot. The page link may show a newer release later.	−USD 14.97 million Exact value Exact value: -14967150 USD 2021-10-01 – 2022-09-30: -14967150 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · cbdMD, Inc. · 2022-09-30 cbdMD, Inc. (edgar:1644903) Operating Cash Flow: -14967150 USD Concept: fundies:OperatingCashFlow Period: 2021-10-01 to 2022-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903/explain?concept=fundies%3AOperatingCashFlow&period=2022-09-30&surface=latest&period_type=duration&start=2021-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14967150 USD (2021-10-01 to 2022-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774923035228/ycbd20230930_10k.htm#908407 Filing: 000143774923035228 The citation records this snapshot. The page link may show a newer release later.	USD 688,680 Exact value Exact value: 688680 USD 2021-10-01 – 2022-09-30: 688680 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · cbdMD, Inc. · 2022-09-30 cbdMD, Inc. (edgar:1644903) Capital Expenditure: 688680 USD Concept: fundies:CapitalExpenditure Period: 2021-10-01 to 2022-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903/explain?concept=fundies%3ACapitalExpenditure&period=2022-09-30&surface=latest&period_type=duration&start=2021-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 688680 USD (2021-10-01 to 2022-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774923035228/ycbd20230930_10k.htm#912483 Filing: 000143774923035228 The citation records this snapshot. The page link may show a newer release later.	−USD 15.66 million Calculation and evidence -14967150 − 688680 USD Exact free cash flow: -15655830 USD 2021-10-01 – 2022-09-30: -14967150 USD · Inspect Operating Cash Flow · Source 2021-10-01 – 2022-09-30: 688680 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · cbdMD, Inc. · 2022-09-30 cbdMD, Inc. (edgar:1644903) Free cash flow: -15655830 USD Concept: free-cash-flow Period: 2021-10-01 to 2022-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14967150 USD (2021-10-01 to 2022-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774923035228/ycbd20230930_10k.htm#908407 Filing: 000143774923035228 Input fundies:CapitalExpenditure: 688680 USD (2021-10-01 to 2022-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774923035228/ycbd20230930_10k.htm#912483 Filing: 000143774923035228 The citation records this snapshot. The page link may show a newer release later.
2023 2022-10-01 – 2023-09-30	−USD 22.94 million Exact value Exact value: -22938209 USD 2022-10-01 – 2023-09-30: -22938209 USD Inspect Net Income Open source Share or cite Citation for Net Income · cbdMD, Inc. · 2023-09-30 cbdMD, Inc. (edgar:1644903) Net Income: -22938209 USD Concept: fundies:NetIncome Period: 2022-10-01 to 2023-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903/explain?concept=fundies%3ANetIncome&period=2023-09-30&surface=latest&period_type=duration&start=2022-10-01&unit=USD&dimensions= Input fundies:NetIncome: -22938209 USD (2022-10-01 to 2023-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774924037840/ycbd20240930c_10k.htm#1832602 Filing: 000143774924037840 The citation records this snapshot. The page link may show a newer release later.	−USD 4.3 million Exact value Exact value: -4302051 USD 2022-10-01 – 2023-09-30: -4302051 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · cbdMD, Inc. · 2023-09-30 cbdMD, Inc. (edgar:1644903) Operating Cash Flow: -4302051 USD Concept: fundies:OperatingCashFlow Period: 2022-10-01 to 2023-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903/explain?concept=fundies%3AOperatingCashFlow&period=2023-09-30&surface=latest&period_type=duration&start=2022-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4302051 USD (2022-10-01 to 2023-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774924037840/ycbd20240930c_10k.htm#971191 Filing: 000143774924037840 The citation records this snapshot. The page link may show a newer release later.	USD 297,549 Exact value Exact value: 297549 USD 2022-10-01 – 2023-09-30: 297549 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · cbdMD, Inc. · 2023-09-30 cbdMD, Inc. (edgar:1644903) Capital Expenditure: 297549 USD Concept: fundies:CapitalExpenditure Period: 2022-10-01 to 2023-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903/explain?concept=fundies%3ACapitalExpenditure&period=2023-09-30&surface=latest&period_type=duration&start=2022-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 297549 USD (2022-10-01 to 2023-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774924037840/ycbd20240930c_10k.htm#976819 Filing: 000143774924037840 The citation records this snapshot. The page link may show a newer release later.	−USD 4.6 million Calculation and evidence -4302051 − 297549 USD Exact free cash flow: -4599600 USD 2022-10-01 – 2023-09-30: -4302051 USD · Inspect Operating Cash Flow · Source 2022-10-01 – 2023-09-30: 297549 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · cbdMD, Inc. · 2023-09-30 cbdMD, Inc. (edgar:1644903) Free cash flow: -4599600 USD Concept: free-cash-flow Period: 2022-10-01 to 2023-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4302051 USD (2022-10-01 to 2023-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774924037840/ycbd20240930c_10k.htm#971191 Filing: 000143774924037840 Input fundies:CapitalExpenditure: 297549 USD (2022-10-01 to 2023-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774924037840/ycbd20240930c_10k.htm#976819 Filing: 000143774924037840 The citation records this snapshot. The page link may show a newer release later.
2024 2023-10-01 – 2024-09-30	−USD 3.7 million Exact value Exact value: -3700126 USD 2023-10-01 – 2024-09-30: -3700126 USD Inspect Net Income Open source Share or cite Citation for Net Income · cbdMD, Inc. · 2024-09-30 cbdMD, Inc. (edgar:1644903) Net Income: -3700126 USD Concept: fundies:NetIncome Period: 2023-10-01 to 2024-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903/explain?concept=fundies%3ANetIncome&period=2024-09-30&surface=latest&period_type=duration&start=2023-10-01&unit=USD&dimensions= Input fundies:NetIncome: -3700126 USD (2023-10-01 to 2024-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774925038435/ycbd20250930_10k.htm#1420866 Filing: 000143774925038435 The citation records this snapshot. The page link may show a newer release later.	−USD 352,792 Exact value Exact value: -352792 USD 2023-10-01 – 2024-09-30: -352792 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · cbdMD, Inc. · 2024-09-30 cbdMD, Inc. (edgar:1644903) Operating Cash Flow: -352792 USD Concept: fundies:OperatingCashFlow Period: 2023-10-01 to 2024-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903/explain?concept=fundies%3AOperatingCashFlow&period=2024-09-30&surface=latest&period_type=duration&start=2023-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -352792 USD (2023-10-01 to 2024-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774925038435/ycbd20250930_10k.htm#887953 Filing: 000143774925038435 The citation records this snapshot. The page link may show a newer release later.	USD 190,015 Exact value Exact value: 190015 USD 2023-10-01 – 2024-09-30: 190015 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · cbdMD, Inc. · 2024-09-30 cbdMD, Inc. (edgar:1644903) Capital Expenditure: 190015 USD Concept: fundies:CapitalExpenditure Period: 2023-10-01 to 2024-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903/explain?concept=fundies%3ACapitalExpenditure&period=2024-09-30&surface=latest&period_type=duration&start=2023-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 190015 USD (2023-10-01 to 2024-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774925038435/ycbd20250930_10k.htm#892092 Filing: 000143774925038435 The citation records this snapshot. The page link may show a newer release later.	−USD 542,807 Calculation and evidence -352792 − 190015 USD Exact free cash flow: -542807 USD 2023-10-01 – 2024-09-30: -352792 USD · Inspect Operating Cash Flow · Source 2023-10-01 – 2024-09-30: 190015 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · cbdMD, Inc. · 2024-09-30 cbdMD, Inc. (edgar:1644903) Free cash flow: -542807 USD Concept: free-cash-flow Period: 2023-10-01 to 2024-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -352792 USD (2023-10-01 to 2024-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774925038435/ycbd20250930_10k.htm#887953 Filing: 000143774925038435 Input fundies:CapitalExpenditure: 190015 USD (2023-10-01 to 2024-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774925038435/ycbd20250930_10k.htm#892092 Filing: 000143774925038435 The citation records this snapshot. The page link may show a newer release later.
2025 2024-10-01 – 2025-09-30	−USD 2.04 million Exact value Exact value: -2040902 USD 2024-10-01 – 2025-09-30: -2040902 USD Inspect Net Income Open source Share or cite Citation for Net Income · cbdMD, Inc. · 2025-09-30 cbdMD, Inc. (edgar:1644903) Net Income: -2040902 USD Concept: fundies:NetIncome Period: 2024-10-01 to 2025-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903/explain?concept=fundies%3ANetIncome&period=2025-09-30&surface=latest&period_type=duration&start=2024-10-01&unit=USD&dimensions= Input fundies:NetIncome: -2040902 USD (2024-10-01 to 2025-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774925038435/ycbd20250930_10k.htm#1420058 Filing: 000143774925038435 The citation records this snapshot. The page link may show a newer release later.	−USD 1.45 million Exact value Exact value: -1452375 USD 2024-10-01 – 2025-09-30: -1452375 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · cbdMD, Inc. · 2025-09-30 cbdMD, Inc. (edgar:1644903) Operating Cash Flow: -1452375 USD Concept: fundies:OperatingCashFlow Period: 2024-10-01 to 2025-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903/explain?concept=fundies%3AOperatingCashFlow&period=2025-09-30&surface=latest&period_type=duration&start=2024-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1452375 USD (2024-10-01 to 2025-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774925038435/ycbd20250930_10k.htm#887308 Filing: 000143774925038435 The citation records this snapshot. The page link may show a newer release later.	USD 184,172 Exact value Exact value: 184172 USD 2024-10-01 – 2025-09-30: 184172 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · cbdMD, Inc. · 2025-09-30 cbdMD, Inc. (edgar:1644903) Capital Expenditure: 184172 USD Concept: fundies:CapitalExpenditure Period: 2024-10-01 to 2025-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903/explain?concept=fundies%3ACapitalExpenditure&period=2025-09-30&surface=latest&period_type=duration&start=2024-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 184172 USD (2024-10-01 to 2025-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774925038435/ycbd20250930_10k.htm#891383 Filing: 000143774925038435 The citation records this snapshot. The page link may show a newer release later.	−USD 1.64 million Calculation and evidence -1452375 − 184172 USD Exact free cash flow: -1636547 USD 2024-10-01 – 2025-09-30: -1452375 USD · Inspect Operating Cash Flow · Source 2024-10-01 – 2025-09-30: 184172 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · cbdMD, Inc. · 2025-09-30 cbdMD, Inc. (edgar:1644903) Free cash flow: -1636547 USD Concept: free-cash-flow Period: 2024-10-01 to 2025-09-30 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1644903?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1452375 USD (2024-10-01 to 2025-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774925038435/ycbd20250930_10k.htm#887308 Filing: 000143774925038435 Input fundies:CapitalExpenditure: 184172 USD (2024-10-01 to 2025-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1644903/000143774925038435/ycbd20250930_10k.htm#891383 Filing: 000143774925038435 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

54 filings · 3,016 latest values · 3,016 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001644903, 1644903, YCBD, edgar:1644903

Also known as LEVEL BEAUTY GROUP, INC., Level Brands, Inc., cbdMD, INC, cbdMD, INC., cbdMD, Inc.

cbdMD, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2024-10-01 – 2025-09-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation